Article Details
Retrieved on: 2025-03-17 18:10:40
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
KIRKLAND — Pfizer Canada's IXIFI (infliximab for injection) will be available in Canada as of April 1, 2025. IXIFI is a biosimilar to Remicade ( ...
Article found on: www.canadianmanufacturing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here